Results 251 to 260 of about 761,204 (307)

Liver Abnormalities During Growth Hormone Treatment

Journal of Pediatric Gastroenterology and Nutrition, 2000
ABSTRACTBackgroundOccasional and transient increase in liver enzymes is reported during growth hormone (GH) treatment in girls with Turner syndrome (TS).MethodsRetrospectively, the specific role of GH treatment on liver and muscular enzymes was evaluated in 78 patients (48 boys; age range 4.0–20.8 years) affected by GH deficiency (GHD) who had been ...
SALERNO, MARIACAROLINA, Di Maio, S, Ferri, P, Lettiero, T, Di Maria, F, Vajro, P.   +5 more
openaire   +4 more sources

Predicting Response to Growth Hormone Treatment

The Indian Journal of Pediatrics, 2011
Despite extensive experience over the past 25 y in managing growth failure with growth hormone (rhGH), predicting treatment efficacy in individual children remains a challenge. In this paper, the authors present the methods that are currently available to clinicians for predicting the growth response, and other more sophisticated techniques which have ...
Patel, Leena, Clayton, Peter E.
openaire   +3 more sources

Evaluating growth hormone treatment

Nursing Standard, 1992
The consequences in later life for people whose growth in childhood has been restricted can be profound, often with severe emotional or psychological effects. The author defines the causes of short stature and describes clinical trials being undertaken to evaluate the use of growth hormone in children who do not appear to have growth hormone deficiency.
openaire   +2 more sources

Growth hormone treatment in non-growth hormone-deficient short children

Journal of Endocrinological Investigation, 2005
The unlimited availability of GH obtained by recombinant DNA technology has allowed optimization of treatment in GH-deficient (GHD) children. At the same time it has prompted a number of studies in conditions not characterized by GHD such as Turner syndrome, intrauterine growth retardation, chronic renal failure and other chromosomal and genetic ...
S, Loche, M R, Casini, G M, Ubertini, M, Cappa   +3 more
openaire   +2 more sources

Robinow Syndrome with Growth Hormone Deficiency: Treatment with Growth Hormone

Journal of Pediatric Endocrinology and Metabolism, 1999
We describe a 5 years and nine months old boy who presented with facial features, vertebral anomalies and dwarfism consistent with Robinow syndrome. Investigations revealed growth hormone (GH) deficiency to be the cause of his dwarfism. We reviewed data on four other patients with Robinow syndrome from the Genentech National Cooperative Growth Study ...
S, Castells, A, Chakurkar, Q, Qazi, W, Bastian   +3 more
openaire   +2 more sources

Growth Hormone Treatment of Non–Growth Hormone-Deficient Growth Disorders

Endocrinology and Metabolism Clinics of North America, 2007
Although a large body of data on efficacy and safety of growth hormone (GH) treatment for various non-growth hormone-deficient (GHD) growth disorders has accumulated from a combination of clinical trial and postmarketing sources in the last 20 years or more, there remain limitations.
openaire   +2 more sources

Long-term growth hormone treatment in growth hormone deficient adults

Acta Endocrinologica, 1991
Abstract. Growth hormone treatment in GH-deficient adults has proved beneficial in recent short-term trials, but long-term results have not yet been reported. Thirteen GH-deficient adults (4 females, 9 males; mean (sem) age 26.4 (1.7) years), who had completed 4 months of GH therapy in a double-blind placebo-controlled cross-over study were followed ...
J O, Jørgensen, S A, Pedersen, L, Thuesen, J, Jørgensen, J, Møller, J, Müller, N E, Skakkebaek, J S, Christiansen   +7 more
openaire   +2 more sources

Changes with growth hormone treatment in growth hormone deficient children

Pediatrics International, 1995
AbstractA total of 54 previously untreated patients (15 girls, 39 boys) with poor growth due to idiopathic growth hormone deficiency (IGHD) were treated with human growth hormone (hGH), continuously up to 4 years. All of the patients had a peak hGH level which was below 10 ng/mL after at least two pharmacological tests and/or blunted physiologic hGH ...
G, Ocal, M, Berberoglu, S, Akçurin, N, Memioglu, A, Ikinciogullari   +4 more
openaire   +2 more sources

Treatment of radiation‐induced growth hormone deficiency with growth hormone‐releasing hormone

Clinical Endocrinology, 1997
In children with hypothalamic causes for GH deficiency there are theoretical reasons why a GHRH analogue might be better than conventional GH therapy in promoting growth.OBJECTIVEWe have aimed to determine the efficacy and safety of growth hormone‐releasing hormone (GHRH) (1–29)‐NH2 given as a twice daily subcutaneous injection in the treatment of ...
A L, Ogilvy-Stuart, H F, Stirling, C J, Kelnar, M O, Savage, D B, Dunger, J M, Buckler, S M, Shalet   +6 more
openaire   +2 more sources

Growth Hormone Treatment in Non‐Growth Hormone‐Deficient Children: Effects of Stopping Treatment

Acta Paediatrica, 1990
ABSTRACT. Overnight physiological growth hormone (GH) secretion was evaluated in 95 short, prepubertal children (73 boys, 22 girls). All the children were below the 3rd centile for height and achieved CH levels greater than 15 mU/1 following pharmacological stimulation.
F M, Ackland, J, Jones, J M, Buckler, D B, Dunger, P H, Rayner, M A, Preece   +5 more
openaire   +2 more sources